Drugging the undruggable

Bringing Chemistry to Life

Visit https://thermofisher.com/bctl to register for your free Bringing Chemistry to Life T-shirt and https://www.thermofisher.com/chemistry-podcast/ to access the extended video version of this episode and the episode summary sheet, which contains links to recent publications and additional content recommendations for our guest.

You can access the extended video version of this episode via our YouTube channel to hear, and see, more of the conversation!

Chemical biology is a relatively recent discipline where thinking about biomolecules as big organic molecules isn’t shocking, but it was completely revolutionary just 3 or 4 decades ago. What is undeniable is that chemistry offers a new lens to observe, interact with and alter biological phenomena. Chemistry opens the possibility to understand biomolecules at the atomic level and to leverage traditional organic chemistry methods to change their function, ultimately influencing macroscopic biological phenomena.

Dr. Shanique Borteley Alabi has been thinking about how chemicals can influence humans ever since childhood observations of her grandfather at work in his pharmacy, in Ghana. She now uses chemistry to influence the interaction between cellular proteins by designing small molecules that work as “glues” for macromolecules.

She spent her PhD developing “proteolysis targeted chimeras” (ProTaC), the use of small molecules with affinity for both a specific protein target and for kinases that tag proteins to initiate their degradation. She now works on similar concepts to selectively initiate and promote the interaction between natural proteins with the objective of amplifying specific natural pathways to treat disease. This is the frontier of drug development, going beyond simple competitive inhibition and promising a way to develop drugs for undruggable targets.

We read every email so please share your questions and feedback with us!

• Email [e-mail]

About Your Host

Born and raised in Italy, Paolo Braiuca, a PhD in pharmaceutical sciences, co-founded a startup company after conducting research in biocatalysis in Italy and the UK. He transitioned from R&D to business development, working in commercial, product management, and marketing roles in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK. A busy father of four, if asked, he’ll call himself a “maker” at heart and enjoys inventing electronic devices in his free time.